Reforgene named a 2022 potential unicorn enterprise of Huangpu District and Guangzhou Development District

Recently, the Science and Technology Bureau of Huangpu District, Guangzhou, announced the 2022 list of unicorn (potential unicorn) enterprises of Huangpu District and Guangzhou Development District. Reforgene was successfully selected as a potential unicorn enterprise, proving that it has received high recognition from the competent authorities in terms of innovation capability, development potential, industry position and development speed.

Unicorn (potential unicorn) enterprises are typical representatives of the new economy, playing an important role in opening up new fields and new tracks, shaping new development drivers and advantages, and promoting high-quality regional development. This 2022 unicorn (potential unicorn) enterprise list of Huangpu District and Guangzhou Development District was selected from thousands of enterprises through multi-dimensional consideration, choosing the outstanding representatives with the strongest comprehensive strength, aiming to strengthen precise services for unicorn enterprises and promote their high-quality development.

Reforgene stood out in this selection, fully demonstrating its strong development potential. As a representative enterprise in China's gene editing drug innovation field, Reforgene, since its establishment in 2019, has always been driven by gene editing technology and dedicated to the birth of novel medicines, with pipeline programs in hematology, ophthalmology, liver and central nervous system fields. At present, its independently developed transfusion-dependent beta-thalassemia gene editing medicine RM001 has achieved leading excellent efficacy, with Phase I clinical trials nearing completion and Phase II clinical trials planned for 2024. This achievement of Reforgene demonstrates its unique competitiveness in the gene editing field and brings new hope and possibilities to the medical community.

Winning the honor of "Potential Unicorn Enterprise" is not only recognition and encouragement from Huangpu District and Guangzhou Development District, but also a weighty social responsibility. "The road ahead is long and far; I will search high and low." Reforgene is always on the road, upholding the philosophy of "Innovation for Life", based on revolutionary gene technology, adhering to independent R&D and innovation, and providing accessible, curative medicines for patients with serious diseases in China and around the world.